Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025)

Eton Pharmaceuticals has disclosed Change in Accured Expenses across 8 years of filings, most recently posting $426000.0 for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 79.15% year-over-year to $426000.0; the TTM figure through Dec 2025 stood at $1.0 million (down 31.87% YoY), while the FY2025 annual figure was $1.0 million, down 31.87% from the prior year.
• Change in Accured Expenses came in at $426000.0 for Q4 2025 at Eton Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q4 2024 to a low of -$1.6 million in Q1 2024.
• Average Change in Accured Expenses over 5 years is $326850.0, with a median of $397000.0 recorded in 2021.
• Year-over-year, Change in Accured Expenses soared 4230.0% in 2023 and tumbled 232.28% in 2024.
• Over 5 years, Change in Accured Expenses stood at $120000.0 in 2021, then plunged by 153.33% to -$64000.0 in 2022, then surged by 2246.88% to $1.4 million in 2023, then jumped by 48.69% to $2.0 million in 2024, then slumped by 79.15% to $426000.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $426000.0 in Q4 2025, $1.8 million in Q3 2025, and $172000.0 in Q2 2025.